Concepedia

Colin Molloy

CM

Statistics

Publications

13

Citations

1.7K

H-Index

13

Active since

2005

Affiliations

University of Glasgow(Current)

Monash University

University of Leicester

University of Cambridge

University of Nottingham

Colin Molloy is an author at University of Glasgow specializing in neuroscience, neurodegenerative diseases, and life sciences.

Publications per year

2005–2022

13

Publications

13

Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice

Julie A. Moreno, Mark Halliday, Colin Molloy et al. · Science Translational Medicine · 2013 · 574 citations

Life Sciences, Neurobiology, Neuroscience +17

Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice

Mark Halliday, Helois Radford, Karlijn A. M. Zents et al. · Brain · 2017 · 295 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration

Diego Peretti, Amandine Bastide, Helois Radford et al. · Nature · 2015 · 251 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs<i>in Vitro</i>and<i>in Vivo</i>

Karen Thompson, Elham Khajehali, Sophie J. Bradley et al. · ACS Pharmacology & Translational Science · 2018 · 195 citations · Full text

Medicine, Neuroscience, Pharmacology +13

From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease

Alastair Brown, Sophie J. Bradley, Fiona H. Marshall et al. · Cell · 2021 · 97 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

1–5 of 13